ITRM vs SLB · rev $390.0K vs P/E 12, rev $35.71B
Iterum Therapeutics PLC (ITRM) versus Schlumberger NV (SLB) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Schlumberger NV (SLB) is a oil & gas equipment & services company listed on US.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported SLB revenue for 2025-12-31 was $35.71B. Net income was $3.37B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
ITRM currently screens at market cap $38.6M. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
Not investment advice. Open the ITRM and SLB stock pages for the full models.
Not investment advice.